CE vs HCA · rev $10.28B vs P/E 17, rev $75.60B
Celanese Corporation (CE) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
CE currently screens at market cap $5.92B. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the CE and HCA stock pages for the full models.
Not investment advice.